Skip to content
value.today

Strata Oncology, Inc.

Total raised
$18 M
2 rounds on record
Latest round
$12 M
Apr 2018
First round on record
Feb 2016
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Strata Oncology, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2018$12 MNo. 2$10 to $50 million

Strata Oncology, Inc.: Raise no. 2, Apr 2018

Investors in this round

7 investors had bought by the notice of May 11, 2018: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$12 M of $25 M offered; $13 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Daniel Rhodes · Executive Officer, Director · CEO
  • Matthew Martin · Executive Officer · CFO
  • Jan Garfinkle · Director
  • Jeffrey Williams · Director
  • Keith Flaherty · Director
  • Nicole Walker · Director
  • Prem Tumkosit · Director
  • William Burkoth · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Daniel R. Rhodes, Ceo. Source: SEC Form D, newest notice filed May 11, 2018. Read the notice at the SEC.

equitySEC
Feb 2016$6 MNo. 1$2 to $10 million

Strata Oncology, Inc.: Raise no. 1, Feb 2016

Investors in this round

6 investors had bought by the notice of Mar 4, 2016: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $12 M offered; $6 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Daniel Rhodes · Executive Officer, Director · CEO
  • Matthew Martin · Executive Officer · CFO
  • Jeffrey Williams · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Daniel R. Rhodes, CEO & Director. Source: SEC Form D, newest notice filed Mar 4, 2016. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Strata Oncology, Inc. chose not to state its revenue in its newest notice of a funding round (May 2018).

    SEC Form D · May 2018

  • The industry group it chose in its notices: Other.

    SEC Form D · May 2018

That is all the official record says: Strata Oncology, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Strata Oncology, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 7 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Strata Oncology, Inc.
NameRoleNamed in
Daniel RhodesCEOMay 2018
Matthew MartinCFOMay 2018
Daniel RhodesCEOMay 2018
Jan GarfinkleDirectorMay 2018
Jeffrey WilliamsDirectorMay 2018
Keith FlahertyDirectorMay 2018
Nicole WalkerDirectorMay 2018
Prem TumkositDirectorMay 2018
William BurkothDirectorMay 2018